These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16850455)

  • 1. Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia.
    Zhao J; Nassar MA; Gavazzi I; Wood JN
    Genesis; 2006 Aug; 44(8):364-71. PubMed ID: 16850455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.
    Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD
    Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptor-specific gene deletion using heterozygous NaV1.8-Cre recombinase mice.
    Stirling LC; Forlani G; Baker MD; Wood JN; Matthews EA; Dickenson AH; Nassar MA
    Pain; 2005 Jan; 113(1-2):27-36. PubMed ID: 15621361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of sensory neuronal groups in CGRP-cre-ER reporter mice: Comparison to Nav1.8-cre, TRPV1-cre and TRPV1-GFP mouse lines.
    Patil MJ; Hovhannisyan AH; Akopian AN
    PLoS One; 2018; 13(6):e0198601. PubMed ID: 29864146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells.
    Leone DP; Genoud S; Atanasoski S; Grausenburger R; Berger P; Metzger D; Macklin WB; Chambon P; Suter U
    Mol Cell Neurosci; 2003 Apr; 22(4):430-40. PubMed ID: 12727441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia.
    Agarwal N; Offermanns S; Kuner R
    Genesis; 2004 Mar; 38(3):122-9. PubMed ID: 15048809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo.
    Yadav D; Conner JA; Wang Y; Saunders TL; Ubogu EE
    Vascul Pharmacol; 2024 Jun; 155():107369. PubMed ID: 38554988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.
    Nassar MA; Stirling LC; Forlani G; Baker MD; Matthews EA; Dickenson AH; Wood JN
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12706-11. PubMed ID: 15314237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.
    Indra AK; Warot X; Brocard J; Bornert JM; Xiao JH; Chambon P; Metzger D
    Nucleic Acids Res; 1999 Nov; 27(22):4324-7. PubMed ID: 10536138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of NSE-MerCreMer transgenic mice with tamoxifen inducible Cre activity in neurons.
    Kam MK; Lee KY; Tam PK; Lui VC
    PLoS One; 2012; 7(5):e35799. PubMed ID: 22586451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis.
    Zheng B; Zhang Z; Black CM; de Crombrugghe B; Denton CP
    Am J Pathol; 2002 May; 160(5):1609-17. PubMed ID: 12000713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.
    Sohal DS; Nghiem M; Crackower MA; Witt SA; Kimball TR; Tymitz KM; Penninger JM; Molkentin JD
    Circ Res; 2001 Jul; 89(1):20-5. PubMed ID: 11440973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage.
    Henry SP; Jang CW; Deng JM; Zhang Z; Behringer RR; de Crombrugghe B
    Genesis; 2009 Dec; 47(12):805-14. PubMed ID: 19830818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split-CreERT2: temporal control of DNA recombination mediated by split-Cre protein fragment complementation.
    Hirrlinger J; Requardt RP; Winkler U; Wilhelm F; Schulze C; Hirrlinger PG
    PLoS One; 2009 Dec; 4(12):e8354. PubMed ID: 20016782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mice expressing a ligand-inducible cre recombinase in osteoblasts and odontoblasts: a new tool to examine physiology and disease of postnatal bone and tooth.
    Kim JE; Nakashima K; de Crombrugghe B
    Am J Pathol; 2004 Dec; 165(6):1875-82. PubMed ID: 15579432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.
    Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D
    Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.